Herbalife（HLF）株式概要
ハーバライフ・リミテッドはその子会社とともに、北米、メキシコ、中南米、ヨーロッパ、中東、アフリカ、中国、アジア太平洋地域で健康とウェルネス製品を提供している。 詳細
HLF Community Fair Values
Create NarrativeSee what 25 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Herbalife Ltd. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$15.82 |
| 52週高値 | US$20.40 |
| 52週安値 | US$6.59 |
| ベータ | 0.96 |
| 1ヶ月の変化 | 13.89% |
| 3ヶ月変化 | -6.61% |
| 1年変化 | 117.31% |
| 3年間の変化 | 12.52% |
| 5年間の変化 | -68.55% |
| IPOからの変化 | 329.89% |
最新ニュース
HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum
Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.
HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery
Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.
HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures
Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.Recent updates
HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum
Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery
Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures
Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.HLF: 2026 Turnaround Hopes Will Confront Persistent Competitive And Fundamental Risks
The analyst price target for Herbalife has been raised by $1 to $9. Analysts point to largely in line Q4 results, new 2026 guidance, and a mix of Buy, Neutral, and Underperform views that reflect both perceived momentum and ongoing concerns around competition, fundamentals, and valuation.HLF: Turnaround Will Be Driven By 2026 Guidance And Margin Recovery
Narrative Update: Herbalife The updated analyst fair value estimate for Herbalife has moved from $11 to $25, a shift analysts link to refreshed price targets in the $9 to $21 range, stronger Q4 commentary, improved margin assumptions, and a lower discount rate despite mixed views on long term growth and valuation risks. Analyst Commentary Recent Street research on Herbalife reflects a mix of views, but several bullish analysts have been willing to raise price targets or upgrade their stance following recent updates from the company.Herbalife's Turnaround Accelerates With Ronaldo's Pro2col
Feb 22HLF: Turnaround Hopes Under New Leadership Will Confront Compressed Sector Multiples
Narrative Update: Herbalife Analyst Price Target Move The blended analyst price target for Herbalife has moved higher, with recent increases such as Mizuho's lift to $13 and Maxim's initiation at $20. Analysts point to an ongoing turnaround, progress under new leadership, and a healthier long term profile for Herbalife's business model, while also noting continuing concerns about competition and broader macro uncertainty.HLF: Recovery Story Under New Leadership Will Face Compressed Sector Multiples
Narrative Update on Herbalife The analyst price target for Herbalife has been revised higher to reflect an updated fair value of $8.00, a lower discount rate of 10.02%, and adjustments to revenue growth, profit margin, and future P/E assumptions, as analysts factor in recent target hikes, Buy initiations, and views of a continuing recovery path under new leadership. Analyst Commentary Recent Street research on Herbalife reflects a mix of optimism about a potential recovery and caution around execution and valuation risks.Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth
Jan 22
HLF: Turnaround And Margin Recovery Under New Leadership Will Face Valuation Constraints
The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations. Analyst Commentary Recent research on Herbalife reflects a mix of optimism about the company’s turnaround efforts and caution about broader sector and macro headwinds.HLF: Recovery Path Under New Leadership Will Likely Deliver Disappointing Multiple Expansion
Analysts have modestly raised their fair value estimate for Herbalife from approximately $9.67 to $12.00 per share, citing a lower perceived risk profile, steady growth and margin assumptions, and a more constructive view on future earnings multiples as fundamentals continue on a recovery path under new leadership. Analyst Commentary Analyst sentiment around Herbalife is gradually improving as execution under new leadership gains traction and forward growth expectations firm up, though views on the pace and durability of the recovery remain mixed.HLF: Recovery Path Under New Leadership Will Likely Prove Overpriced
Analysts have modestly raised their price target on Herbalife to $11 from $10, citing a gradually lower perceived risk profile, steady long term growth and margin assumptions, and growing confidence that the company is on a recovery path under new leadership, with a potential return to volume growth by fiscal 2026. Analyst Commentary Bullish analysts point to the recent rating upgrade and price target increase as evidence that sentiment around Herbalife is gradually improving, with expectations that operational execution will support a more favorable risk and reward profile over the next several years.HLF: Uncertainty Around CEO Transition Will Challenge Near-Term Momentum
Herbalife’s analyst price target has been raised to $11 from $10, as analysts point to recovering fundamentals and the company’s strategic leadership changes as promising signs for future growth. Analyst Commentary Analysts have recently weighed in on Herbalife, offering a mix of optimism about its improving fundamentals and some caution about ongoing risks.We Think That There Are Some Issues For Herbalife (NYSE:HLF) Beyond Its Promising Earnings
Nov 13The Market Doesn't Like What It Sees From Herbalife Ltd.'s (NYSE:HLF) Earnings Yet
Oct 29At US$8.75, Is Herbalife Ltd. (NYSE:HLF) Worth Looking At Closely?
Sep 26A Look At The Intrinsic Value Of Herbalife Ltd. (NYSE:HLF)
Jul 24There's No Escaping Herbalife Ltd.'s (NYSE:HLF) Muted Earnings Despite A 26% Share Price Rise
Jun 25Herbalife (NYSE:HLF) Hasn't Managed To Accelerate Its Returns
May 28Herbalife's (NYSE:HLF) Earnings Offer More Than Meets The Eye
May 08Herbalife Ltd.'s (NYSE:HLF) Share Price Boosted 63% But Its Business Prospects Need A Lift Too
Mar 13Herbalife: The Battleground Stock Is Showing Some Turnaround Potential
Feb 24Is It Time To Consider Buying Herbalife Ltd. (NYSE:HLF)?
Feb 19Returns At Herbalife (NYSE:HLF) Appear To Be Weighed Down
Jan 29Herbalife: Down In The Dumps, But Maybe Worth Exploring
Jan 21Investors Still Aren't Entirely Convinced By Herbalife Ltd.'s (NYSE:HLF) Earnings Despite 27% Price Jump
Nov 12We Think You Can Look Beyond Herbalife's (NYSE:HLF) Lackluster Earnings
Nov 06Herbalife: A Top Short Squeeze Idea, Turning Higher In Price
Nov 05What Does Herbalife Ltd.'s (NYSE:HLF) Share Price Indicate?
Nov 01Herbalife: The Biggest Value Trap Of The Moment
Oct 03Herbalife (NYSE:HLF) May Have Issues Allocating Its Capital
Oct 02
Revitalizing Sales Through Innovative Distributor Engagement And Digital Transformation Initiatives
Herbalife's focus on distributor engagement and digital transformation aims to reverse recruitment decline and enhance sales efficiency, potentially boosting revenue.Herbalife Ltd. (NYSE:HLF) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 14株主還元
| HLF | US Personal Products | US 市場 | |
|---|---|---|---|
| 7D | -3.9% | 0.4% | 0.6% |
| 1Y | 117.3% | -15.0% | 28.4% |
業界別リターン: HLF過去 1 年間で-15 % の収益を上げたUS Personal Products業界を上回りました。
リターン対市場: HLF過去 1 年間で28.4 % の収益を上げたUS市場を上回りました。
価格変動
| HLF volatility | |
|---|---|
| HLF Average Weekly Movement | 8.8% |
| Personal Products Industry Average Movement | 9.1% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
安定した株価: HLF 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: HLFの 週次ボラティリティ ( 9% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1980 | 8,500 | Stephan Gratziani | www.herbalife.com |
ハーバライフ・リミテッドは子会社とともに、北米、メキシコ、中南米、ヨーロッパ、中東、アフリカ、中国、アジア太平洋地域で健康とウェルネス製品を提供している。同社は、ミール・リプレースメント、プロテイン・シェイク、ドリンク・ミックス、減量サプリメント、ヘルシー・スナック、新陳代謝を高めるお茶などの体重管理製品、ハーブ、ビタミン、ミネラル、その他の天然成分を含む機能性飲料や栄養補助食品からなる標的栄養製品、エネルギー、スポーツ、フィットネス製品、顔のスキンケア、ボディケア、ヘアケア製品を提供している。同社はまた、スタートアップキット、販売ツール、教材などの文献、販促、その他の資料も提供している。販売代理店、独立系サービスプロバイダー、自社運営の小売店やプラットフォームを通じて製品を販売している。以前はハーバライフ・ニュートリション・リミテッドとして知られていたが、2023年4月にハーバライフ・リミテッドに社名を変更した。ハーバライフ・リミテッドは1980 年に設立され、カリフォルニア州ロサンゼルスに本社を置く。
Herbalife Ltd. 基礎のまとめ
| HLF 基礎統計学 | |
|---|---|
| 時価総額 | US$1.68b |
| 収益（TTM） | US$228.30m |
| 売上高(TTM) | US$5.04b |
7.2x
PER（株価収益率0.3x
P/SレシオHLF は割高か？
公正価値と評価分析を参照収益と収入
| HLF 損益計算書（TTM） | |
|---|---|
| 収益 | US$5.04b |
| 売上原価 | US$1.11b |
| 売上総利益 | US$3.92b |
| その他の費用 | US$3.69b |
| 収益 | US$228.30m |
直近の収益報告
Dec 31, 2025
次回決算日
May 06, 2026
| 一株当たり利益（EPS） | 2.21 |
| グロス・マージン | 77.87% |
| 純利益率 | 4.53% |
| 有利子負債／自己資本比率 | -390.7% |
HLF の長期的なパフォーマンスは？
過去の実績と比較を見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/04 06:58 |
| 終値 | 2026/05/04 00:00 |
| 収益 | 2025/12/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Herbalife Ltd. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。15
| アナリスト | 機関 |
|---|---|
| John Staszak | Argus Research Company |
| Meredith Adler | Barclays |
| Brian Wang | Barclays |